Immunoglobulins and complement in pleural effusions associated with bronchogenic carcinoma

Area of Science:

• Immunology
• Oncology
• Thoracic Medicine

Background:

• Pleural effusions are common in lung cancer.
• Immunoglobulin and complement levels in pleural fluid are not well understood, especially in malignant effusions.

Purpose of the Study:

• To compare immunoglobulin and complement component levels in malignant pleural effusions (lung cancer) versus non-malignant pleural effusions.
• To assess the diagnostic potential of these markers.

Main Methods:

• Measurement of IgG, IgA, IgM, total hemolytic complement (CH50), and complement components (C1q, C3, C4, C6, C7) in 29 pleural effusion samples.
• Comparison of levels between 18 malignant (lung cancer) and 11 non-malignant effusions.

Main Results:

• Significantly lower levels of IgG were observed in malignant pleural effusions compared to non-malignant ones.
• No significant differences were found in other immunoglobulins (IgA, IgM), CH50, or individual complement components between the groups.
• Hemolytic activity was present in most effusions, indicating the presence of classical complement pathway components.

Conclusions:

• Lower IgG levels may indicate malignancy in pleural effusions, but require further validation for diagnostic use.
• Complement system components are generally preserved in pleural effusions, regardless of malignancy.
• Expanded research is necessary to determine the diagnostic utility of IgG in malignant pleural effusions associated with bronchogenic carcinoma.